Two Essential Aspects to Ensuring the Success of Allogeneic Therapies

Jay Tong, MD, Founder and Chairman

AllCells’ Founder and Chairman, Dr. Jay Tong, discusses how flexibility and donor management are two essential aspects for successful allogeneic cell therapies. As allogeneic therapies continue to increase and improve within the field, these two aspects can be the difference between a broken pipeline and successfully getting your therapy to market.

Have a question? Let’s chat.